Your browser doesn't support javascript.
loading
Dysfunction of the adhesion G protein-coupled receptor latrophilin 1 (ADGRL1/LPHN1) increases the risk of obesity.
Dietzsch, André Nguyen; Al-Hasani, Hadi; Altschmied, Joachim; Bottermann, Katharina; Brendler, Jana; Haendeler, Judith; Horn, Susanne; Kaczmarek, Isabell; Körner, Antje; Krause, Kerstin; Landgraf, Kathrin; Le Duc, Diana; Lehmann, Laura; Lehr, Stefan; Pick, Stephanie; Ricken, Albert; Schnorr, Rene; Schulz, Angela; Strnadová, Martina; Velluva, Akhil; Zabri, Heba; Schöneberg, Torsten; Thor, Doreen; Prömel, Simone.
Affiliation
  • Dietzsch AN; Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, Leipzig, Germany.
  • Al-Hasani H; Institute for Clinical Biochemistry and Pathobiochemistry, Medical Faculty, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Altschmied J; German Center for Diabetes Research (DZD e.V.), Munich-Neuherberg, Germany.
  • Bottermann K; Cardiovascular Degeneration, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital and Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Brendler J; Cardiovascular Research Institute (CARID), Medical Faculty, University Hospital and Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Haendeler J; Cardiovascular Research Institute (CARID), Medical Faculty, University Hospital and Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Horn S; Institute of Pharmacology, Medical Faculty, University Hospital and Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Kaczmarek I; Institute of Anatomy, Medical Faculty, Leipzig University, Leipzig, Germany.
  • Körner A; Cardiovascular Degeneration, Clinical Chemistry and Laboratory Diagnostics, Medical Faculty, University Hospital and Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Krause K; Cardiovascular Research Institute (CARID), Medical Faculty, University Hospital and Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Landgraf K; Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, Leipzig, Germany.
  • Le Duc D; Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, Leipzig, Germany.
  • Lehmann L; Center for Pediatric Research, Hospital for Children and Adolescents, Medical Faculty, Leipzig University, Leipzig, Germany.
  • Lehr S; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.
  • Pick S; Department of Endocrinology, Nephrology, Rheumatology, Leipzig University Medical Center, Leipzig, Germany.
  • Ricken A; Center for Pediatric Research, Hospital for Children and Adolescents, Medical Faculty, Leipzig University, Leipzig, Germany.
  • Schnorr R; Institute of Human Genetics, Leipzig University Medical Center, Leipzig, Germany.
  • Schulz A; Institute of Cell Biology, Department of Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Strnadová M; Institute for Clinical Biochemistry and Pathobiochemistry, Medical Faculty, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Velluva A; German Center for Diabetes Research (DZD e.V.), Munich-Neuherberg, Germany.
  • Zabri H; Institute of Cell Biology, Department of Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Schöneberg T; Institute of Anatomy, Medical Faculty, Leipzig University, Leipzig, Germany.
  • Thor D; Institute of Cell Biology, Department of Biology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Prömel S; Rudolf Schönheimer Institute of Biochemistry, Medical Faculty, Leipzig University, Leipzig, Germany.
Signal Transduct Target Ther ; 9(1): 103, 2024 Apr 26.
Article in En | MEDLINE | ID: mdl-38664368
ABSTRACT
Obesity is one of the diseases with severe health consequences and rapidly increasing worldwide prevalence. Understanding the complex network of food intake and energy balance regulation is an essential prerequisite for pharmacological intervention with obesity. G protein-coupled receptors (GPCRs) are among the main modulators of metabolism and energy balance. They, for instance, regulate appetite and satiety in certain hypothalamic neurons, as well as glucose and lipid metabolism and hormone secretion from adipocytes. Mutations in some GPCRs, such as the melanocortin receptor type 4 (MC4R), have been associated with early-onset obesity. Here, we identified the adhesion GPCR latrophilin 1 (ADGRL1/LPHN1) as a member of the regulating network governing food intake and the maintenance of energy balance. Deficiency of the highly conserved receptor in mice results in increased food consumption and severe obesity, accompanied by dysregulation of glucose homeostasis. Consistently, we identified a partially inactivating mutation in human ADGRL1/LPHN1 in a patient suffering from obesity. Therefore, we propose that LPHN1 dysfunction is a risk factor for obesity development.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Peptide / Receptors, G-Protein-Coupled / Obesity Limits: Animals / Humans Language: En Journal: Signal Transduct Target Ther Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Peptide / Receptors, G-Protein-Coupled / Obesity Limits: Animals / Humans Language: En Journal: Signal Transduct Target Ther Year: 2024 Document type: Article Affiliation country: Country of publication: